44 Matching Annotations
  1. Oct 2025
  2. 54.241.53.176 54.241.53.176
    1-s2.0-S2589004225019108-main-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    54.241.53.176/a2cead7372cd5656ca58f963b054c227add92e0d/1-s2.0-S2589004225019108-main-html.html
  3. Jul 2025
  4. www.biorxiv.org www.biorxiv.org
    Single administration of mosaic-8b RBD-nanoparticle vaccine prepared with atomic layer deposition technology elicits broadly neutralizing anti-sarbecovirus responses
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2025.06.16.660007v1
  5. May 2025
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12077133/
  7. Apr 2025
  8. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11998534/
  9. journals.asm.org journals.asm.org
    Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    journals.asm.org/doi/10.1128/jvi.00242-25
  10. Jan 2025
  11. www.sciencedirect.com www.sciencedirect.com
    Designed mosaic nanoparticles enhance cross-reactive immune responses in mice
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867424014284
  12. Dec 2024
  13. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11601353/
  14. Sep 2024
  15. www.sciencedirect.com www.sciencedirect.com
    Discovery and characterization of a pan-betacoronavirus S2-binding antibody
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0969212624003691
  16. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11398412/
  17. Aug 2024
  18. www.sciencedirect.com www.sciencedirect.com
    Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867424008468
  19. Jul 2024
  20. www.cell.com www.cell.com
    Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/cell-reports/abstract/S2211-1247(24)00849-0
  21. May 2024
  22. www.biorxiv.org www.biorxiv.org
    Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.05.20.595020v1
  23. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11077997/
  24. Apr 2024
  25. www.biorxiv.org www.biorxiv.org
    Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.03.11.583978v1
  26. Mar 2024
  27. onlinelibrary.wiley.com onlinelibrary.wiley.com
    Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    onlinelibrary.wiley.com/doi/10.1002/jmv.29520
  28. Feb 2024
  29. www.biorxiv.org www.biorxiv.org
    Mosaic sarbecovirus vaccination elicits cross-reactive responses in pre-immunized animals
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.02.08.576722v1
  30. Jan 2024
  31. www.sciencedirect.com www.sciencedirect.com
    Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867423014009
  32. Dec 2023
  33. www.sciencedirect.com www.sciencedirect.com
    Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761323004855
  34. Nov 2023
  35. link.springer.com link.springer.com
    SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    link.springer.com/article/10.1007/s00018-023-05011-3
  36. Oct 2023
  37. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10606793/
  38. www.sciencedirect.com www.sciencedirect.com
    Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004223020862
  39. www.sciencedirect.com www.sciencedirect.com
    Continued evasion of neutralizing antibody response by Omicron XBB.1.16
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124723012056
  40. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10515800/
  41. Jun 2023
  42. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10305169/
  43. May 2023
  44. www.sciencedirect.com www.sciencedirect.com
    Neutralization Escape of Omicron XBB, BR.2, and BA.2.3.20 Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379123001635
  45. Apr 2023
  46. www.sciencedirect.com www.sciencedirect.com
    Enhanced Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124723004540
  47. Mar 2023
  48. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9972997/
  49. Feb 2023
  50. www.sciencedirect.com www.sciencedirect.com
    Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004223002031
  51. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9882202/
  52. Jan 2023
  53. journals.asm.org journals.asm.org
    Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    journals.asm.org/doi/10.1128/mbio.03176-22
  54. Dec 2022
  55. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Enhanced Neutralization Resistance of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9678813/
  56. Nov 2022
  57. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9606073/
  58. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9603827/
  59. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9603825/
  60. Oct 2022
  61. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Evasion of Neutralizing Antibody Responses by the SARS-CoV-2 BA.2.75 Variant
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9515334/
  62. 52.53.155.43 52.53.155.43
    A Microarray Patch SARS-CoV-2 Vaccine Induces Sustained Antibody Responses and Polyfunctional Cellular Immunity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/930bc08144a97604b3aba650218d62e0f5ec0931/1-s2.0-S2589004222013177-main-html.html
  63. Sep 2022
  64. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9458542/
  65. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9413709/
  66. Aug 2022
  67. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9353602/
  68. 52.53.155.43 52.53.155.43
    https://medrxiv.org/cgi/content/10.1101/2022.01.03.21268582
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/29c3e315cf2d23005021f240f790281059e1fe7d/2022.01.03.21268582.full-html.html
  69. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9327628/
  70. May 2022
  71. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Neutralization of SARS-CoV-2 Omicron Sub-lineages BA.1, BA.1.1, and BA.2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9035359/
  72. Apr 2022
  73. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9018067/
  74. Aug 2021
  75. www.sciencedirect.com www.sciencedirect.com
    Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2352396421003182